艾德生物：首次回购约9.14万股

Group 1 - Company announced a share repurchase of approximately 91,400 shares, representing 0.02% of the total share capital, at a maximum price of 21.97 CNY per share and a minimum price of 21.83 CNY per share, with a total expenditure of about 2 million CNY [1] - The company's revenue for the year 2024 is entirely derived from the in vitro diagnostics industry, accounting for 100% of its revenue [1] Group 2 - The current market capitalization of the company is 8.6 billion CNY [2]